MEDAVAIL HOLDINGS INC's ticker is MDVL and the CUSIP is 58406B103. A total of 54 filers reported holding MEDAVAIL HOLDINGS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,735 | -14.5% | 15,237 | 0.0% | 0.00% | -100.0% |
| Q1 2023 | $4,367 | -4.4% | 15,237 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $4,568 | -61.9% | 15,237 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $12,000 | -47.8% | 15,237 | 0.0% | 0.00% | -33.3% |
| Q2 2022 | $23,000 | +53.3% | 15,237 | 0.0% | 0.00% | +200.0% |
| Q1 2022 | $15,000 | -28.6% | 15,237 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $21,000 | -52.3% | 15,237 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $44,000 | -76.5% | 15,237 | 0.0% | 0.00% | -73.3% |
| Q2 2021 | $187,000 | -12.2% | 15,237 | 0.0% | 0.02% | -11.8% |
| Q1 2021 | $213,000 | -7.0% | 15,237 | 0.0% | 0.02% | -10.5% |
| Q4 2020 | $229,000 | – | 15,237 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 3,885,951 | $54,403,000 | 59.34% |
| Ally Bridge Group (NY) LLC | 2,920,780 | $40,891,000 | 7.84% |
| Redmile Group, LLC | 11,724,726 | $164,146,000 | 2.31% |
| PURA VIDA INVESTMENTS, LLC | 2,342,213 | $31,634,000 | 0.90% |
| Endurant Capital Management LP | 229,767 | $3,217,000 | 0.84% |
| Northern Right Capital Management, L.P. | 150,000 | $2,100,000 | 0.59% |
| Monashee Investment Management LLC | 230,568 | $3,228,000 | 0.50% |
| CIGNA INVESTMENTS INC /NEW | 514,668 | $7,205,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,142,552 | $15,996,000 | 0.34% |
| Maven Securities LTD | 483,384 | $6,545,000 | 0.29% |